Adtalem Global Education's Michael Betz sells $379,992 in stock
Michael Betz, President of Walden University and Chief Digital Officer at Adtalem Global Education Inc. (NYSE:ATGE), has ...
Prime Medicine: Gene Editing Company, Risky Investment
Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.
BMO raises Adtalem stock price target to $115, maintains Outperform
BMO Capital Markets expressed a positive outlook on Adtalem Global Education (NYSE:ATGE), as analyst Jeffrey Silber increased the company's price target from $108.00 to $115.00. The firm sustained its ...
Adtalem Global Education price target raised to $115 from $108 at BMO Capital
BMO Capital raised the firm’s price target on Adtalem Global Education (ATGE) to $115 from $108 and keeps an Outperform rating on the shares.